CINCINNATI, March 30, 2011 /PRNewswire/ -- LasikPlus®
surgeon Dr. Lewis Groden presented
results from a first-of-its-kind, comparative study at the American
Society of Cataract and Refractive Surgery (ASCRS) Symposium
revealing that LASIK procedures performed with modern excimer laser
technology produce excellent results and very high patient
satisfaction rates.
Each LCA-Vision (Nasdaq: LCAV) LasikPlus® vision center
currently offers patients a choice of multiple state-of-the-art
LASIK excimer platforms.
"Every day we witness life-transforming outcomes from this
procedure and, as a company, we set out to determine scientifically
whether technological advancements are producing outcomes that are
as good as we believe," said Dr. Groden, surgeon at the Tampa
LasikPlus® vision center and Director of Cornea Service for
the University of South Florida
Department of Ophthalmology.
The study included an analysis of 180 procedures performed on 90
patients, who were treated between October
20 and December 19, 2008. Three months post-operatively, 89
percent of these patients had uncorrected visual acuity of 20/20 or
better, and 93 percent of these patients strongly agreed with the
statement, "My vision is excellent."
LasikPlus®, in conjunction with industry collaborators,
conducted the randomized study of the different state-of-the-art
excimer laser technologies at three LasikPlus® vision
centers. Independent calibration of the equipment was performed on
each procedure day, visual acuity was determined by use of
standardized vision charts and all 90 patients participated in
follow-up interviews three months following their procedure. The
data was analyzed by the independent research firm.
"After conducting this study at FDA standards, we concluded that
we deliver the highest quality care with results equal to any
technology in use today. Further, customer satisfaction rates were
very high, validating our internal LasikPlus® surveys.
In fact, 95 percent of our patients would recommend
LasikPlus® to a friend or co-worker according to our most
recent monthly survey," added Dr. Groden.
"We're thrilled to now be able to offer our patients even
greater confidence by showing independent research that verifies
the quality of procedures performed on these modern platforms," he
added. "Excimer technology has come a long way since FDA approval
of photorefractive keratectomy in late 1995."
For more information about the ASCRS Symposium or the research,
visit http://www.ascrs.org/11am/index.cfm.
About LCA-Vision/LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction
services under the LasikPlus® brand, operates 54
LasikPlus® fixed-site laser vision correction centers in 26
states and 41 markets in the United
States. Since the FDA approved photorefractive keratectomy
in late 1995, we have performed nearly 1.2 million laser vision
correction procedures at our vision centers.
LasikPlus® is partnering with the Wounded Warrior Project
and the Fisher House Foundation to provide free LASIK services to
wounded American veterans and their caregivers. To date, this
partnership has led to the corrective surgery for nearly 100
wounded warriors and caregivers—putting their lives back in focus.
For additional company information, please visit
www.lasikplus.com.
Contacts:
|
Jennifer Riegert
|
|
|
513-271-7222 x 22
(Office)
|
|
|
513-309-2920 (Cell)
|
|
|
jriegert@wordsworthweb.com
|
|
|
|
SOURCE LCA-Vision Inc.